NCT02499354View on ClinicalTrials.gov

Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 28, 2021

Study Completion Date

May 31, 2022

Conditions
Restless Legs SyndromeIron Deficiency Anemia
Interventions
DRUG

Ferumoxytol intravenous

IV iron, 2 vials of 510 mg given 2-7 days apart

DRUG

Ferrous sulfate

Oral iron, 325 mg tabs taken morning and evening

Trial Locations (1)

21237

Auerbach Hematology Oncology Assoc, Baltimore

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

Auerbach Hematology Oncology Associates P C

OTHER